Brokerages Set Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Target Price at $11.00
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research firms that are covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year target […]
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research firms that are covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year target […]
